TRINITY BIOTECH PLC (TRIB)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Annual

0 35M 70M 105M FY20: 102M FY21: 81.1M FY22: 62.5M FY23: 56.8M FY24: 61.6M FY20 FY21 FY22 FY23 FY24

Gross Profit Annual

0 20M 40M 60M FY20: 48.6M FY21: 33.5M FY22: 17.3M FY23: 19.4M FY24: 21.4M FY20 FY21 FY22 FY23 FY24

Operating Income Annual

-30M -20M -10M 0 10M 20M 30M FY20: 82K FY21: 3.9M FY22: -19.3M FY23: -27M FY24: -21.2M FY20 FY21 FY22 FY23 FY24

Net Income Annual

-45M -30M -15M 0 15M 30M 45M FY20: -6M FY21: -1.9M FY22: -43.6M FY23: -36.9M FY24: -31.2M FY20 FY21 FY22 FY23 FY24

Cost of Revenue Annual

0 20M 40M 60M FY20: 53.4M FY21: 47.7M FY22: 45.3M FY23: 37.4M FY24: 40.1M FY20 FY21 FY22 FY23 FY24

Operating Cash Flow Annual

-18M -9M 0 9M 18M 27M FY20: 23.8M FY21: 13.2M FY22: -921K FY23: -11.6M FY24: -4.2M FY20 FY21 FY22 FY23 FY24

Free Cash Flow Annual

-14M -7M 0 7M 14M 21M FY20: 20.6M FY21: 11.4M FY22: -2M FY23: -12.4M FY24: -4.6M FY20 FY21 FY22 FY23 FY24

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 150M 300M 450M FY20: 37.7M FY21: 37M FY22: 79.5M FY23: 153.1M FY24: 359.2M FY20 FY21 FY22 FY23 FY24

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.